Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Letters

• Publication date

  2008-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2008.02.023PMID 18358600PMCID PMC2432085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth

  2007cited by this paper
• Tumor hypoxia in cancer therapy.

  2007cited by this paper
• Inhibition of ADAM17 reduces hypoxia‐induced brain tumor cell invasiveness

  2007cited by this paper
• Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation

  2006cited by this paper
• PDT‐associated host response and its role in the therapy outcome

  2006cited by this paper
• EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing.

  2006cited by this paper
• Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.

  2006cited by this paper
• Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment

  2006cited by this paper
• Combination of Surgical Resection and Photodynamic Therapy of 9L Gliosarcoma in the Nude Rat

  2006cited by this paper
• Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α

  2006cited by this paper
• Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin.

  2005cited by this paper
• Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

  2005cited by this paper
• Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17

  2005cited by this paper
• Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?

  2004cited by this paper
• Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.

  2004cited by this paper
• The Matrix Metalloproteinase Inhibitor Prinomastat Enhances Photodynamic Therapy Responsiveness in a Mouse Tumor Model

  2004cited by this paper
• Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model.

  2004cited by this paper
• Epidermal growth factor receptor family (EGFR, ErbB2–4) in gliomas and meningiomas

  2004cited by this paper
• The hypoxic tumour microenvironment and metastatic progression

  2004cited by this paper
• Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor

  2004influential reference
• Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.

  2004cited by this paper
• TACE/ADAM17 Processing of EGFR Ligands Indicates a Role as a Physiological Convertase

  2003influential reference
• Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide*

  2003cited by this paper
• Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.

  2002cited by this paper
• Tumor necrosis factor-a converting enzyme

  2002cited by this paper
• EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines.

  2002cited by this paper
• Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.

  2001cited by this paper
• Invasiveness in vitro and biological markers in human primary glioblastomas

  2001cited by this paper
• Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression.

  2000cited by this paper
• Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].

  2000cited by this paper
• Expression of hypoxia‐inducible factor 1α in brain tumors

  2000cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)

  1999cited by this paper
• Hypoxia‐mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression

  1999cited by this paper
• Ectodomain shedding of TGF‐α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades

  1999cited by this paper
• EGF receptor.

  1999cited by this paper
• Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.

  1999cited by this paper
• Cytostatic Agents in the Management of Malignant Gliomas.

  1998cited by this paper
• Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain

  1998cited by this paper
• Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

  1998cited by this paper
• Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor*

  1998cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

  1997cited by this paper
• Membrane protein secretases.

  1997cited by this paper
• Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

  1997cited by this paper
• A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

  1997cited by this paper
• Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.

  1996cited by this paper
• Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation.

  1996cited by this paper
• Sensitivity of 9L gliosarcomas to photodynamic therapy.

  1996cited by this paper
• A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.

  1995cited by this paper
• A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes

  1995cited by this paper
• HOW DOES PHOTODYNAMIC THERAPY WORK?

  1992cited by this paper
• Oxygen consumption and diffusion effects in photodynamic therapy.

  1991cited by this paper
• Photodynamic therapy of brain tumours--post-operative "field fractionation".

  1991cited by this paper

• Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma

  2024influential citation
• Clinical Benefits of Photodynamic Therapy Using Talaporfin Sodium in Patients With Isocitrate Dehydrogenase-Wildtype Diagnosed Glioblastoma: A Retrospective Study of 100 Cases

  2024cites this paper
• Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

  2022cites this paper
• Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy

  2022cites this paper
• Low-dose photodynamic therapy-induced increase in the metastatic potential of pancreatic tumor cells and its blockade by simvastatin.

  2020cites this paper
• Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events

  2020cites this paper
• FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma

  2018cites this paper
• Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway.

  2016cites this paper
• Correlation between ADAM 17 protein expression level and prognosis of neuroglioma

  2016cites this paper
• Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity

  2016cites this paper
• Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy

  2016cites this paper
• MicroRNAs in human glioblastoma: from bench to beside.

  2015cites this paper
• The response of neurons and glial cells of crayfish to photodynamic treatment: Transcription factors and epigenetic regulation

  2015cites this paper
• 9-Hydroxypheophorbide α-mediated photodynamic therapy induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in Hep-2 cells via ROS-mediated suppression of the ERK pathway.

  2014cites this paper
• Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid.

  2014cites this paper
• Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway

  2014cites this paper
• Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies.

  2014cites this paper
• ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway

  2013cites this paper
• Gallic acid: molecular rival of cancer.

  2013cites this paper
• ADAM17 promotes glioma cell malignant phenotype

  2012cites this paper
• MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells

  2012cites this paper
• Migration of adhesive glioma cells: front propagation and fingering.

  2012cites this paper
• Induction of Immune Mediators in Glioma and Prostate Cancer Cells by Non-Lethal Photodynamic Therapy

  2011influential citation
• TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.

  2011cites this paper
• On the Role of Phosphatidylinositol 3-Kinase, Protein Kinase B/Akt, and Glycogen Synthase Kinase-3β in Photodynamic Injury of Crayfish Neurons and Glial Cells

  2011cites this paper
• ADAM‐17/Tumor Necrosis Factor‐α‐Converting Enzyme Inhibits Neurogenesis and Promotes Gliogenesis from Neural Stem Cells

  2011cites this paper
• The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigation

  2010cites this paper
• Interstitial Photodynamic Therapy of Brain Tumors

  2010cites this paper
• Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells.

  2010influential citation
• TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy

  2010cites this paper
• ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation

  2009cites this paper
• Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia

  2009cites this paper
• ADAM17: The new face of breast cancer-promoting metalloprotease activity

  2009cites this paper
• ADAM proteins - therapeutic potential in cancer.

  2008cites this paper
• Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor

  2008cites this paper